INTERNATIONAL PATENT: GAMAMABS PHARMA FILES APPLICATION FOR "HUMANIZED ANTI-HUMAN HER3 ANTIBODIES AND USES THEREOF"

GENEVA, Dec. 11 -- GAMAMABS PHARMA (Centre Pierre Potier1, place Pierre PotierONCOPOLE entree B31106 TOULOUSE) filed a patent application (PCT/EP2025/065004) for "HUMANIZED ANTI-HUMAN HER3 ANTIBODIES AND USES THEREOF" on May 30, 2025. With publication no. WO/2025/248097, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HERCEND, Thierry (8 rue Campagne Premiere75014 PARIS), DUBREUIL, Olivier (1 rue des Marronniers31190 MAURESSAC), BARRET, Jean-Marc (5 rue du Tresor81100 CASTRES), PROST, Jean-Francois (25 avenue Debasseux781...